European Archives - Page 277 of 1124 - European Medical Journal

Importance of Early Hepatitis C Screening in Perinatally Exposed Children

A recent study has underscored the critical need for early hepatitis C virus (HCV) screening in children born to HCV-positive mothers.

Influenza Viruses with Reduced Susceptibility to Oseltamivir Detected Globally

Researchers have reported the emergence and spread of influenza A(H1N1)pdm09 viruses with a 13-fold reduced inhibition by oseltamivir.

Ruxolitinib Effective for Steroid-Refractory Graft-Versus-Host Disease

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment

Explore HAE insights from EAACI 2024 with expert panel on treatment challenges, patient care, and new oral therapies

Sandoz’s Claire D’Abreu-Hayling on leading with love

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Spoonful of technology: May-June 2024

Explore the top tech stories that have shaped pharma in recent months as we explore implants to AI models, with a particular focus on antimicrobial resistance.

Women in Europe Are Receiving More Cycles of IVF: ESHRE 2024

Uptake of in vitro fertilisation and intrauterine insemination has increased among women in Europe, according to data presented at the ESHRE 40th annual meeting.

Socioeconomic Status Affects Fertility Treatment Outcomes: ESHRE 2024

New research presented at ESHRE highlights significant social disparities in achieving live births following assisted reproductive technology treatment.

Plants for Joints Trial: Breaking News from EULAR 2024

Results presented at EULAR 2024, show reductions in DAS28 scores among rheumatoid arthritis patients following a plant-based, whole-food diet, exercise, and stress management regime.

Phase III IMROZ Study of Isa-VRd in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Watch Thierry Facon highlight the Phase III IMROZ study: a global, randomised, Phase III, open-label study evaluating the efficacy and…